Nadia Merchant

Nadia Merchant, MD is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at UT Southwestern Medical Center. She joined the institution in February 2024 after completing her medical degree at Weill Cornell Medical College in Qatar. Her clinical training includes pediatric residency at Dayton Children's/Wright State University, genetics residency and pediatric endocrine fellowship at Texas Children's Hospital.

Her research focuses on bone health, skeletal dysplasia, genetic growth disorders, and endocrinopathies in neuromuscular disorders. Key areas include the intersection of genetics and endocrinology, particularly in rare conditions such as achondroplasia and RASopathies. She has led clinical trials for vosoritide and denosumab in pediatric populations, emphasizing translational research and drug implementation guidelines.

Her publications span over a decade, with recent work addressing novel therapies for growth disorders, iodine deficiency hypothyroidism, and endocrine surveillance in Duchenne muscular dystrophy. She actively collaborates in global initiatives like the International RASopathies Symposium to advance care for rare genetic conditions.

Dr. Merchant’s work bridges clinical care and research, advocating for multidisciplinary approaches to skeletal and metabolic disorders. She contributes to consensus guidelines and serves on committees shaping pediatric endocrinology practices at UT Southwestern and beyond.